Allison Drew
About Allison Drew
Allison Drew is a Director at MOMA Therapeutics, where she has worked since 2022. She holds an M.S. in Environmental Science, Policy and Management from the University of California, Berkeley, and a B.S. in Biology from Cornell University, with extensive experience in drug discovery and a focus on epigenetics and oncology.
Current Role at MOMA Therapeutics
Allison Drew serves as the Director at MOMA Therapeutics, a position she has held since 2022. In this role, she leverages her extensive background in drug discovery and her expertise in target identification and validation. Her contributions are vital to the company's mission of advancing therapeutic solutions. Drew previously held the position of Principal Scientist at MOMA Therapeutics from 2020 to 2022, where she managed drug discovery projects, guiding them from early target identification to development candidate nomination.
Education and Academic Background
Allison Drew earned her Master of Science degree in Environmental Science, Policy and Management from the University of California, Berkeley, where she studied from 2000 to 2002. Prior to this, she completed her Bachelor of Science degree in Biology at Cornell University, attending from 1994 to 1998. This academic foundation has equipped her with a strong understanding of biological sciences and environmental factors relevant to her work in drug discovery and development.
Professional Experience at Amgen
Drew has significant experience at Amgen, where she worked in various roles over several years. She served as a Senior Associate Scientist from 2011 to 2012, and prior to that, she held the position of Associate Scientist from 2008 to 2011. Additionally, she worked as a Senior Associate from 2005 to 2008. Her time at Amgen allowed her to develop a robust skill set in drug discovery and project management.
Research Experience and Contributions
Before her tenure at MOMA Therapeutics, Allison Drew held positions that contributed to her research expertise. She worked as a Research Technician at USDA-ARS from 2003 to 2005 and as a Research Assistant at George Washington University from 1999 to 2000. These roles provided her with hands-on experience in research methodologies and techniques, further enhancing her capabilities in the field of drug discovery.
Expertise in Epigenetics and Oncology
Allison Drew possesses strong expertise in epigenetics and oncology, areas that are crucial for drug discovery projects. Her knowledge in these fields has been instrumental in her roles, particularly in managing projects from target identification to candidate nomination. This expertise supports her contributions to advancing therapeutic solutions at MOMA Therapeutics.